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it is crucial to better understand the processes that direct the for- 
mation of a functional collagen network in cartilage. The present 
study was designed to test whether initial blockage of collagen 
crosslinking would stimulate collagen synthesis and whether sub- 
sequent formation of the crosslinks would result in a functional 
collagen network. 
Methods: Bovine articular chondrocytes were cultured in alginate 
beads for 5 weeks in the presence or absence of the lysyl oxidase 
inhibitor BAPN (0.1 mM, 0.25mM or 0.5mM) followed by 5 weeks 
without BAPN. Proteoglycan synthesis (colorimetric assay), colla- 
gen synthesis and amout of crosslinks were measured biochem- 
ically (HPLC) at several timepoints. 
Results: Inhibition of lysyl oxidase with BAPN caused an in- 
crease in total collagen levels. As from week 5, there was ap- 
proximately 1.5 times more collagen deposition in cultures sup- 
plemented with BAPN than in the control condition, reaching 
1.84 times more after 10 weeks (8.9 I~g collagen/bead vs. 16.4 
i~g/bead). There was no difference in the proteoglycan deposi- 
tion. Until week 6 there was a low amount of crosslinks in the 
collagen detectable in the matrix produced by chondrocytes in 
the presence of BAPN (0.18 pmol HP/pmol collagen) whereas 
collagen deposited without the presence of BAPN had a higher 
level of crosslinking (0.53 pmol HP/pmol collagen). From week 8 
on, 3 weeks after removal of BAPN, the amount of crosslinks in 
all three conditions approached the level of the control condition 
(0.70 HP/collagen in the control condition vs. 0.60 HP/collagen 
with BAPN) in week 10. No dosis effect was observed for BAPN. 
Conclusion: Blockage of collagen crosslinking with BAPN at first 
stimulates collagen synthesis compared to the control condition, 
followed by the formation of an equal amount of crosslinks after 
removal of the lysyl oxidase inhibitor. The effect of more colla- 
gen with the same amount of crosslinks per collagen molecule 
on mechanical properties requires further investigation. 
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The goal of this study is to demonstrate the role of the subchon- 
dral bone in the development and progression of hyaline cartilage 
degeneration in the knee joint. 
We utilized a murine model of Osteogenesis Imperfecta (OI) to 
determine whether abnormalities in bone predispose the joint to 
the development of osteoarthritis. 
OI is a genetic disease of humans that is caused by a mutation in 
type I collagen and is expressed in bone and ligament, but not in 
hyaline articular cartilage. The animals employed were a knock-in 
model of type IV OI and age matched wild-type (WT) controls. 
High resolution micro-computed tomography (micro-CT) and 
micro-magnetic resonance imaging (micro-MRI) with gadolinium 
contrast enhancement, as well as histologic evaluation, were em- 
ployed to study the knee joints of a pair of OI and a pair of WT 
animals age 2, 4, 6, and 12 months and one animal each at 22 
months. 
The results document for the first time that OI mice develop 
rapidly progressive OA. Micro-CT and micro-MRI documented 
age-related joint space narrowing, extra-articular ossification, and 
progressive subchondral bone thickening and cyst formation in 
the OI mice. Histologic examination showed typical aggressive 
cartilage destruction with osteophyte formation in the OI mice. 
These results clearly demonstrate that abnormalities in subchon- 
dral bone can lead to rapidly progressive OA in the absence of 
intrinsic cartilage abnormalities. 
Moreover, the data suggest that OI mice might serve as a useful 
model of OA that can be employed to examine the pathophysiol- 
ogy of cartilage damage as well as the impact of therapies. 
P102 
MATRIX METALLOPROTEASE ACTIVITY BUT NOT 
CYSTEINE PROTEASE ACTIVITY IS ESSENTIAL FOR 
ARTICULAR CARTILAGE DEGRADATION 
BC Sondergaard 1, K Henriksen 2, H Wulf 1 , S Ostergaard 2, U 
Schurigt 3, R BaQer 3, C Chrisriansen 1 , P Qvist 1 , MA Karsdal 2 
1Pharmacology and Biomarkers, Nordic Bioscience & Center for 
Clinical and Basic Research, Herlev/Ballerup, Denmark; 
2 pharmos Bioscience, Herlev, Denmark; 3Dept. of Pathology, 
Friedrich Schiller Universi~ Jena, Germany 
Objective: Both matrix metalloprotease (MMP) activity and 
cathepsin K activity have been implicated in cartilage turnover. 
We investigated the relative contribution of MMP activity and 
cathepsin K activity in cartilage degradation usingex vivo and in 
vivo models. 
Methods: Bovine articular cartilage explants were cultured in 
presence of oncostatin M (OSM) 10 ng/ml, tumor necrosis 
factor-a (TNF-~) 20 ng/ml in the presence or absence of the 
broad-spectrum MMP activity inhibitor GM6001 and the cys- 
teine protease inhibitor E64. Cartilage degradation was evalu- 
ated in the conditioned medium by measurement of crosslinked 
C-telopeptide fragments of type II collagen (CTX-II) and gly- 
cosaminoglycans (GAG), which were compared to immunohisto- 
chemical evaluations of proteoglycans and CTX-II. We assessed 
MMP expression by gelatine zymography and cathepsin K ex- 
pression by immunohistochemistry. 
Results: OSM and TNF-~ in combination induced a 500-fold in- 
crease in cartilage degradation products measured by CTX-II 
(P<0.001) compared to vehicle control. The growth factors po- 
tently induced MMP expression, assessed by zymography, and 
cathepsin K expression investigated by immunohistochemistry. 
Inhibition of MMP activity by GM6001 completely abrogated CTX- 
II release (P<0.001) and inhibited proteoglycan release by 72% 
(p<0.001). In contrast, E64 resulted in an increased CTX-II re- 
lease by 100% (P<0.05) and inhibited GAG release by 33% 
(p<0.01). An up-regulation of CTX-II fragments was confirmed 
in vivo in cathepsin K null mice. 
Conclusions: Inhibition of MMP activity reduced both proteo- 
glycan-loss and type II collagen degradation. In contrast, inhibi- 
tion of cysteine proteases resulted in an increase rather than a 
decrease in collagen type II degradation, suggesting compensa- 
tion by other proteases. 
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Aim of study: In this study we investigated if the inhibition of 
MRC is able to modulate the inflammatory response in human 
OA chondrocytes. 
Methods: Human OA chondrocytes were isolated from cartilage 
obtained from the femoral heads of patients undergoing joint re- 
placement surgery. Rotenone, 3-nitropropionic acid (NPA), an- 
timycin A, sodium azide and oligomycin were employed to in- 
hibit complex I, II, III, IV or V of CRM, respectively. LPS was em- 
ployed as positive control. Cell viability was evaluated using the 
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MTT assay. Expression of mRNA for chemokines and cytokines 
was analyzed by ribonuclease protection assay and expresion of 
mRNA for metaloprotease (MMP-1), by RT-PCR. NO production 
was evaluated by the Greiss Method and PGE2, IL-8 and IL-6 by 
ELISA. 
Results: Firstly, when we examined the individual effect of mito- 
chondrial inhibitors, we observed that antimycin A and oligomycin 
decrease cell viability in a dose- and time-dependent manner 
(at 48 h, antimycin A: 524-7 and oligomycin: 424-5 vs basal 
100%, n=6, p<0.01). However, the rest of MRC inhibitors (I, II, 
and IV) did not modified the viability. Secondly, we explored the 
chemokines and cytokines mRNA and we found that only an- 
timycin A and oligomycin induced in a dose-dependent manner 
the mRNA of chemokines IL-8 and MCP-1. Other chemokines 
such as, Rantes, 1-309, and IP-10 were not modified. Thereafter, 
we examined whether the rise in IL-8 mRNA in cultured chon- 
drocytes was accompanied by the synthesis of IL-8 protein and 
we found that it was induced by antimycin A and oligomycin (at 
24 h; basal, 624-14; antimycin A, 1354-34, oligomycin, 3254-12 
pg/ml/50.000 cells, n=4). In relation to cytokines evaluated we 
found that again, only antimycin A and oligomycin induced in a 
dose-dependent manner the mRNA of cytokines IL-6, IL-1 b; and 
IL-18. Other cytokines such as, IL-12, IL-10, IL-lb; orthe IL-1Ra 
were not significantly modified. The rest of inhibitors did not mod- 
ified the mRNA expression studied. Thereafther we determined 
that the rise in IL-6 mRNA in cultured chondrocytes was accom- 
panied by the synthesis of IL-6 protein (at 24 h; basal, 404-12; 
antimycin A, 1804-44, oligomycin, 4254-12 pg/ml/50.000 cells, 
n=4). When MMP-1 was examined, it was found that oligomycin 
increases significantly its expression in a dose-dependent man- 
ner.Thirdly, when we assesed NO and PGE2 production we found 
that neither inhibitor employed were able to modulate NO synthe- 
sis. However, in relation to PGE2, we described as antimycin A 
and oligomycin increase significantly PGE2 after 48 h of stim- 
ulation (basal, 1054-15; antimycin A, 8254-34 and oligomycin, 
11124-325 pg/ml/50.000 cells). 
Conclusion: These results show that mitochondrial dysfunction 
could modulate inflammatory response in human OA chondro- 
cytes and that inhibition of complex III and V could be especially 
relevant in relation to inflammatory response. These data could 
be important for a better understanding of the role of mitochon- 
dria in the pathogenesis of cartilage degradation. 
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Initial disorder in OA is the metabolic abnormalities of chondro- 
cyte characterized by secretion of proteinases, suppression of 
of matrix synthesis, and apoptosis of chondrocyte. It has been 
reported that OA is associated with underlying abnormalities in 
bone structure and mineralization. Analysis of Framingham study 
indicated that low serum levels of vitamin D appears to be as- 
sociated with an increased risk for progression of the knee OA. 
Association of early knee OA with a polymorphism of the vitamin 
D receptor gene is also shown. Objective of this study is to de- 
termine the effect of 1,25(OH)2D3 on chondrocyte cell death and 
the expression of apoptosis-related molecules in STR/ort mice, 
naturally developing OA model. 
Materials and Methods: Thirty nine male STR/ort mice were 
studied by randomly assigning them to two treatment groups 
in study of six months duration. 1,25(OH)2D3 (0.11~g/kg body 
weight)were administrated subcutaneously from 8 weeks of age 
and sacrificed 25 or 35 weeks of age. Toluidine blue stain- 
ing, TUNEL assay, and immunohistochemistry against apoptosis- 
related molecules including iNOS, TNF-~, TRAIL, caspase-3, 
FAS, DR-5 were performed on serial paraffin sections of the knee 
joint from mice. 
Results: Histological examination showed STR/ort mice exhib- 
ited OA lesions of knee joint at 35 weeks after birth, however 
no changes at 25 weeks. These OA lesions were suppressed 
in mice treated with 1,25(OH)2D3. TUNEL positive chondrocytes 
were observed frequently in control mice at 35 weeks after birth. 
1,25(OH)2D3 treatment decreased the number of TUNEL posi- 
tive chondrocytes. Immunohistological examination indicated that 
chondrocytes expressed iNOS, TNF-~, TRAIL, caspase-3, and 
FAS DR-5 at 35 weeks. 1,25(OH)2D3 treatment decreased num- 
ber of chondrocytes which were positive for these apoptosis- 
related molecules. Among these molecules, iNOS expression 
was suppressed most significantly with 1,25(OH)2D3 treatment. 
Discussion: In STR/ort mice, chondrocyte cell death is shown 
to be correlated with the progression of OA. Chondrocyte apop- 
tosis is induced with several molecules in vivo and in vitro. 
Present study indicated that 1,25(OH)2D3 suppressed chondro- 
cyte cell death. Administration of 1,25(OH)2D3 also significantly 
suppressed iNOS expression of chondrocyte. We suppose that 
inhibition of chondrocyte cell death may be the one of the path- 
way for the anti-OA effect of 1,25(OH)2D3 observed in this mice. 
Above results suggest 1,25(OH)2D3 may have therapeutic value 
for OA. 
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Purpose: Targeted remodeling of aged bone for repair of micro 
cracks is essential for maintenance of bone quality. How osteo- 
clasts target old bone in order to sustain the quality of the skele- 
ton by constant remodelling is currently not known. 
We investigated whether old bones accumulate signals, which 
target the bone for remodeling by osteoclasts. For this purpose, 
human osteoclast precursors were assessed for their ability to 
survive, adhere, differentiate and resorb old versus young bone. 
Methods: Human CD14+ monocytes were isolated by magnetic 
bead sorting. Differentiation of osteoclasts on young (9-months) 
and old (8-years) bone slices was tested, by culturing the mono- 
cytes in the presence of RANKL and M-CSF for 28 days. Differen- 
tiation and resorption were investigated by measuring the TRAcP 
activity, the CTX release in the conditioned medium and by scor- 
ing the pit area. Osteoclast numbers were assessed by counting 
calcitonin receptor positive cells and by measuring TRAcP activ- 
ity in the conditioned medium. Mature osteoclasts were cultured 
on young and old bone for 9 days followed by measurement of 
osteoclast activity and number. Osteoclast adhesion was investi- 
gated by scoring TRAcP positive osteoclasts on bone slices af- 
ter 1,2 and 6 hours. The quantitative differences between young 
and old bones were assessed by measuring the amount of na- 
